Imaizumi M, Uchida T, Akiyama S, Hirai K, Ichimura I, Fujita K, Takahashi T, Abe T, Kondo T
Jpn J Antibiot. 1985 Jun;38(6):1661-70.
There are few clinical reports about the concentration of ceftizoxime (CZX) in lung tissues. At present, clinically, we report the concentration of the drug in serum and lung tissues on 26 cases of chest disease and an effect of the drug on prophylaxis of postoperative pulmonary infections. Our results are the following; The peak concentration of CZX in serum is 54.7 micrograms/ml at 1 hour after starting drip infusion of CZX 1 g. The serum half-life of CZX (beta phase) is 2.07 hours. The concentration of CZX in lung tissues is from 43.6 to 78.7% of serum level. CZX is useful to prophylaxis of postoperative infections after thoracotomy, especially in case of administration of CZX 1 g just before operation. Eruption was found in 1 of 26 cases. However, no side effects of the drug are noticed in other 25 cases.
关于头孢唑肟(CZX)在肺组织中的浓度,临床报告较少。目前,我们临床报告了26例胸部疾病患者血清和肺组织中该药物的浓度以及该药物对预防术后肺部感染的效果。我们的结果如下:静脉滴注1g CZX 1小时后血清中CZX的峰值浓度为54.7微克/毫升。CZX的血清半衰期(β期)为2.07小时。肺组织中CZX的浓度为血清水平的43.6%至78.7%。CZX对开胸术后感染的预防有效,尤其是在手术前刚好给予1g CZX的情况下。26例中有1例出现皮疹。然而,其他25例未发现该药物的副作用。